BBNX (NASDAQ: BBNX) affiliate notifies planned sale of 16,872 shares via broker
Rhea-AI Filing Summary
Beta Bionics, Inc. affiliate files a Form 144 proposing the resale of 16,872 shares of Common Stock. The filing lists an aggregate offering value of $215,792.88 and shows shares outstanding of 44,561,695 as of 06/02/2026. The shares are described as Restricted Stock Units vesting under a registered plan with a vesting date of 06/01/2026. The broker/dealer listed is Morgan Stanley Smith Barney LLC. The filing also reports a prior sale of 3,384 shares on 03/02/2026 for $41,831.65.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies a planned affiliate resale of vested RSUs totaling 16,872 shares.
The filing identifies 16,872 shares tied to Restricted Stock Units vesting under a registered plan on 06/01/2026 and an aggregate value of $215,792.88. It lists Morgan Stanley Smith Barney LLC as the broker/dealer and reports 44,561,695 shares outstanding as of 06/02/2026. This notice is procedural under Rule 144 and signals intent to resell once conditions are met.
Execution depends on vesting and compliance with resale conditions; cash‑flow treatment is not specified in the excerpt. Subsequent SEC filings or broker disclosures will show actual transactions and timing.
Key Figures
Key Terms
Form 144 regulatory
Restricted Stock Units financial
registered plan regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.